Product
Oral prednisolone + Cyclophosphamide
1 clinical trial
1 indication
Indication
Membranous NephropathyClinical trial
International, Multi-centre Randomised Clinical Trial of Obinutuzumab Versus Corticosteroid and Cyclophosphamide in Primary Membranous Nephropathy (REMIT Trial).Status: Not yet recruiting, Estimated PCD: 2028-01-31